A recent study finds that painkiller abuse and overdose are lower in states with medical marijuana laws on the books.
Neuroscientist Greg Gerdeman, PhD, one of the rare professors to teach the endocannabinoid system in college, challenges health professionals and researchers to study cannabis science and therapeutics.
Many health professionals have little to no experience with cannabis therapeutics and are not able to guide people on this subject. So Project CBD has created a beginner’s guide to cannabidiol & cannabis therapeutics to address key questions of CBD users.
The 2016 meeting of the International Cannabinoid Research Society focused on the latest research in cannabinoid studies and the endocannabinoid system.
Our video series Cannabis Conversations interviews Dr. Ethan Russo on clinical endocannabinoid deficiency and ways to target the endocannabinoid system for therapeutic benefit.
Low-dose and high-dose treatments, protocols for chronic users, and the potential benefits of psychoactivity.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1. Cannabidiol is a profound mood-altering substance, even if it may not have a “high”.
Companion planting is a method of cultivation where plants are grown together to promote a dynamic, flourishing ecosystem. Some cannabis cultivators have begun adopting these practices, resulting in multiple benefits.
Some good news for admirers of the first CBD-rich cultivars discovered in California: The breeder of the infamous Jamaican Lion strain is releasing a new seed line.
Huge interest in the medicinal potential of CBD has catalyzed a rebirth of industrial hemp in the U.S. But is hemp the best source of CBD?
Kevin McKernan on sequencing the cannabis genome and its implications for the cannabis industry and “personalized medicine.”
O’Shaughnessy’s (Winter 2015/16)—the journal that was instrumental in launching Project CBD six years ago—is now available.
Dr. Lester Grinspoon, Emeritus Professor of Psychiatry Harvard Medical School, urges an investigation of medical cannabis for players in the NFL.
An important study from the Journal of Neuroscience shows that marijuana use does not cause structural brain changes.
New evidence marijuana users are much less likely to develop metabolic syndrome, a significant risk factor for obesity, diabetes, and heart disease.